These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16563555)

  • 1. Drug-eluting stents: an innovative multidisciplinary drug delivery platform.
    Burt HM; Hunter WL
    Adv Drug Deliv Rev; 2006 Jun; 58(3):345-6. PubMed ID: 16563555
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents: factors governing local pharmacokinetics.
    Yang C; Burt HM
    Adv Drug Deliv Rev; 2006 Jun; 58(3):402-11. PubMed ID: 16616969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus.
    Machan L
    Adv Drug Deliv Rev; 2006 Jun; 58(3):447-62. PubMed ID: 16713011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethoxyethyl methacrylate-based copolymers--a novel platform for drug-eluting stent coatings.
    Cheng P; Driessen A; Tijsma E; Udipi K
    J Control Release; 2006 Nov; 116(2):e92-4. PubMed ID: 17718991
    [No Abstract]   [Full Text] [Related]  

  • 5. Zotarolimus (ABT-578) eluting stents.
    Burke SE; Kuntz RE; Schwartz LB
    Adv Drug Deliv Rev; 2006 Jun; 58(3):437-46. PubMed ID: 16581153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting stents: beyond the hyperbole.
    Hunter WL
    Adv Drug Deliv Rev; 2006 Jun; 58(3):347-9. PubMed ID: 16600419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.
    Tepe G
    Semin Vasc Surg; 2006 Jun; 19(2):102-8. PubMed ID: 16782516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of sirolimus-eluting stents.
    Kirtane AJ; Leon MB
    Cardiovasc Drug Rev; 2007; 25(4):316-32. PubMed ID: 18078432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.
    Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE
    Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
    Krucoff MW; Boam A; Schultz DG
    Circulation; 2007 Jun; 115(23):2990-4. PubMed ID: 17473280
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stent design and coatings on restenosis and thrombosis.
    Hara H; Nakamura M; Palmaz JC; Schwartz RS
    Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents: the next chapter of the coronary stent saga.
    Meier B
    Am Heart Hosp J; 2007; 5(3):173-6. PubMed ID: 17673861
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-eluting stents: breakthrough or time bomb].
    Lüscher TF; Silber S
    Herz; 2007 Jun; 32(4):265-7. PubMed ID: 17607531
    [No Abstract]   [Full Text] [Related]  

  • 18. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.
    Serruys PW; Daemen J
    Circulation; 2007 Mar; 115(11):1433-9; discussion 1439. PubMed ID: 17344323
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
    Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of drug coating on drug eluting stents].
    Luo LL; Wang GX; Yin TY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.